US › Healthcare

Champions Oncology Inc (CSBR)

US · Healthcare · Biotechnology

$5.45-5.38%
Last close · 2026-08-04

Latest quarter · ended 2026-04-30

Revenue
$13.8M
Revenue YoY
+12.0%
Net profit
$-729,000
Profit YoY
+60.3%
EPS
$-0.05
EPS estimate
$-0.05
Net margin
-5.3%

EPS came in at -0.05 against a street estimate of -0.05 — a beat of 0.0%.

Key statistics

Market cap
$74.5M
Forward P/E
22.9
P/B
18.94
Book value
$0.28
EPS (TTM)
$-0.08
52-week high
$8.74
52-week low
$5.22
50-day MA
$5.98
200-day MA
$6.29
Beta
0.39

Analyst view

Analysts rate Champions Oncology Inc a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $12.00.

Shareholding

Insiders
26.66%
Institutions
41.33%

Largest institutional holders

FundStake
Battery Management Corp17.44%
NEA Management Company, LLC12.34%
Tocqueville Asset Management L.P.2.30%
Vanguard Capital Management, LLC2.16%
Morgan Stanley - Brokerage Accounts1.74%
Renaissance Technologies Corp1.05%
BlackRock Inc0.89%
Mink Brook Asset Management LLC0.80%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Champions Oncology Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.